Showing results (251-260 of 290) with videos related to
Sort By:
Pageof 29
JAMA Neurology|February 15, 2013
APOE ε4 increases risk for dementia in pure synucleinopathiesDebby Tsuang, James B Leverenz, Oscar L Lopez, et al.Acta Neuropathologica|September 3, 2024
Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuumAmanda E Denning, Ranjit Ittyerah, Lisa M Levorse, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersPaul A Yushkevich, Sadhana Ravikumar, Laura E M Wisse, et al.Nature Aging|March 12, 2026
Microglia protein profiles in CSF across Alzheimer's disease clinical stagesElena-Raluca Blujdea, Pieter van Bokhoven, Pamela V Martino-Adami, et al.Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.Acta Neuropathologica Communications|October 25, 2021
Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathologySadhana Ravikumar, Laura E M Wisse, Sydney Lim, et al.The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.The Journal of Prevention of Alzheimer'S Disease|January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degenerationJesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.Biorxiv : the Preprint Server for Biology|February 24, 2025
Developing an anatomically valid segmentation protocol for anterior regions of the medial temporal lobe for neurodegenerative diseasesNiyousha Sadeghpour, Sydney A Lim, Anika Wuestefeld, et al.Pageof 29